DrugPatentWatch Database Preview
Drugs in Development Information for Misonidazole
Drug Development Status for Misonidazole: Patents, clinical trial progress, indications
Misonidazole is an investigational drug.
There have been 13 clinical trials for Misonidazole.
The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2007.
The most common disease conditions in clinical trials are Glioblastoma, Lung Neoplasms, and Carcinoma, Non-Small-Cell Lung. The leading clinical trial sponsors are National Cancer Institute (NCI), Proacta, Incorporated, and AstraZeneca.
Summary for Misonidazole
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,197 |
| WIPO Patent Applications | 825 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 2 (2007-08-01) |
| Vendors | 18 |
Recent Clinical Trials for Misonidazole
| Title | Sponsor | Phase |
|---|---|---|
| Feasibility of FMISO in Brain Tumors | National Cancer Institute (NCI) | Phase 2 |
| Feasibility of FMISO in Brain Tumors | OHSU Knight Cancer Institute | Phase 2 |
| Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment | Abramson Cancer Center of the University of Pennsylvania | Phase 1 |
Clinical Trial Summary for Misonidazole
Top disease conditions for Misonidazole
Top clinical trial sponsors for Misonidazole
US Patents for Misonidazole
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
